EUVIMEDEUVIMED entdecken
Crossref

Venous thromboembolic complications in patients newly diagnosed with cholangiocarcinoma

Piangrawee Niprapan, Phichayut Phinyo, Worakitti Lapisatepun, Chaiyut Charoentum, Adisak Tantiworawit, Ekarat Rattarittamrong, Lalita Norasetthada, Pokpong Piriyakhuntorn, Thanawat Rattanathammethee, Sasinee Hantrakool, Nonthakorn Hantrakun, Teerachat Punnachet und 1 weitere

Journal of Thrombosis and Thrombolysis · 2025

DOI: 10.1007/s11239-025-03099-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Thrombolysis, 2025. Verfasst von Piangrawee Niprapan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Venous Thromboembolism, Bile Duct Neoplasms. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholangiocarcinoma (CCA) is an uncommon cancer, with limited data available on the incidence of cancer-associated thrombosis in CCA patients. This was a single-center, retrospective study conducted in a university-based hospital in Thailand. We included consecutive patients newly diagnosed with CCA between January 2019 and December 2022. The study outcomes focused on the incidence of venous thromboembolism (VTE) and all-cause mortality within 12 months of diagnosis. A total of 450 patients were included in the study, with a median follow-up time of 212 days, and 61.8% of participants were male. The one-year incidence of VTE was 15.3%, with a median time to VTE occurrence of 6 days (Q1-Q3: 1-86 days). Multivariable analysis indicated that age ≤ 55 years (hazard ratio 2.34, 95% confidence interval [CI] 1.40-3.88, p = 0.001), ECOG performance status ≥ 2 (HR 2.53, 95% CI 1.41-4.53, p = 0.002), stage IV cancer (HR 1.84, 95% CI 1.14-3.00, p = 0.013), and total bilirubin ≤ 13 mg/dL (HR 4.11, 95% CI 1.67-10.15, p = 0.002) were associated with VTE occurrence. During follow-up, all-cause mortality was 57.3%, and VTE presence increased the risk of all-cause mortality, with an HR of 1.41 (95% CI 1.02-1.94, p = 0.035). The incidence of VTE following a diagnosis of CCA was notably high. CCA patients who developed VTE were observed to be at a heightened risk of all-cause mortality. Therefore, VTE should be recognized as one of the significant complications among CCA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaVenous ThromboembolismBile Duct NeoplasmsHumansMaleFemaleMiddle AgedRetrospective StudiesThailandAgedIncidenceRisk FactorsAdultFollow-Up Studies

Stichwörter der Autor:innen

Cancer associated thrombosisCholangiocarcinomaVenous thromboembolic complicationsVenous thromboembolism

Autor:innen und Institutionen

  • Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.
  • Center for Clinical Epidemiology and Clinical Statistics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Department of Biomedical Informatics and Clinical Epidemiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Clinical Surgical Research Center, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Oncology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Zitieren

APA

Niprapan, P., Phinyo, P., Lapisatepun, W., Charoentum, C., Tantiworawit, A., Rattarittamrong, E., Norasetthada, L., Piriyakhuntorn, P., Rattanathammethee, T., Hantrakool, S., Hantrakun, N., Punnachet, T., & Chai-Adisaksopha, C. (2025). Venous thromboembolic complications in patients newly diagnosed with cholangiocarcinoma. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-025-03099-x

Vancouver

Niprapan P, Phinyo P, Lapisatepun W, Charoentum C, Tantiworawit A, Rattarittamrong E, et al. Venous thromboembolic complications in patients newly diagnosed with cholangiocarcinoma. Journal of Thrombosis and Thrombolysis. 2025. doi:10.1007/s11239-025-03099-x

BibTeX
@article{Niprapan2025,
  author = {Niprapan, Piangrawee and Phinyo, Phichayut and Lapisatepun, Worakitti and Charoentum, Chaiyut and Tantiworawit, Adisak and Rattarittamrong, Ekarat and Norasetthada, Lalita and Piriyakhuntorn, Pokpong and Rattanathammethee, Thanawat and Hantrakool, Sasinee and Hantrakun, Nonthakorn and Punnachet, Teerachat and Chai-Adisaksopha, Chatree},
  title = {Venous thromboembolic complications in patients newly diagnosed with cholangiocarcinoma},
  journal = {Journal of Thrombosis and Thrombolysis},
  year = {2025},
  doi = {10.1007/s11239-025-03099-x}
}
Kostenlos starten →